Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-043843

Chief Financial Officer sold 1,693 shares at $11.80 ($19,977)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2023-07-28 Sale −1,693 $11.80 $19,977 146,136 D
Open-market sales · 1,693 sh · avg $11.80 · $19,977
Loading xslF345X05/doc4.xml…